Home > Riviste > Minerva Endocrinology > Fascicoli precedenti > Minerva Endocrinology 2021 December;46(4) > Minerva Endocrinology 2021 December;46(4):428-40



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo



Minerva Endocrinology 2021 December;46(4):428-40

DOI: 10.23736/S2724-6507.20.03197-1


lingua: Inglese

Lipid profile in mild subclinical hypothyroidism: systematic review and meta-analysis

Yulia TREISTER-GOLTZMAN 1, 2 , Shaked YARZA 3, Roni PELEG 1, 2

1 Department of Family Medicine and Siaal Research Center for Family Practice and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 2 Clalit Health Services, Southern District, Israel; 3 Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel

INTRODUCTION: Only severe subclinical hypothyroidism (SSCH) with TSH above 10 mIU/L is considered a risk factor of hyperlipidemia and cardiovascular disease. The results of published papers on mild subclinical hypothyroidism (MSCH) with TSH below10 mIU/L are contradictory. The objective of the study was to conduct a systematic review and meta-analysis on lipid profiles in a population of patients with MSCH (TSH10> mIU/L and normal T3, T4) in comparison with euthyroid subjects.
EVIDENCE ACQUISITION: The electronic databases PubMed, CIANHL, Scopus, and Web of Science were searched systematically between August 20, 2018 and September 15, 2018, without limitation on the date of publication or the language. Titles, abstracts and articles were reviewed to identify papers that evaluated lipid profiles in patients with MSCH compared to euthyroid.
EVIDENCE SYNTHESIS: A systematic review of the studies and a meta-analysis using R software (version 3.6.1) were performed. Thirty-five case control and cohort studies were included in the meta-analysis. Total cholesterol (TC), low density lipoprotein (LDL), and triglycerides (TG) were significantly higher and high-density lipoprotein (HDL) was significantly lower in MSCH patients compared to euthyroid individuals. Mean differences (MD) [95% CI] were 12.75 [6.02, 19.48], 10.95 [6.37, 15.54], 19.27 [10.90, 27.64], and -1.81 [-3.38, -0.23], respectively. No significant difference was observed for very low-density lipoproteins (VLDL), apolipoprotein A1 (apoA1), or apolipoprotein B (apoB). The studies were of fair to good quality.
CONCLUSIONS: MSCH is associated with an increase in major atherogenic lipoproteins and should be viewed as a cardiovascular risk factor.

KEY WORDS: Hypothyroidism; Cholesterol; LDL lipoproteins; HDL cholesterol

inizio pagina